coronavirus
cov
envelop
singlestrand
positivesens
rna
virus
display
except
genet
plastic
driven
accumul
point
mutat
recombin
event
genet
variat
respons
continu
emerg
viral
strain
increas
virul
differ
tissu
tropism
andor
expand
host
rang
buonavoglia
et
al
cov
current
classifi
within
four
genera
alphacoronaviru
betacoronaviru
gammacoronaviru
deltacoronaviru
recognis
bat
bird
like
rodent
natur
reservoir
decemb
case
undiagnos
pneumonia
start
report
wuhan
hubei
china
januari
chines
author
indic
novel
cov
associ
sever
respiratori
diseas
first
patient
unexplain
pneumonia
identifi
decemb
came
wuhan
south
china
seafood
market
initi
patient
link
seafood
live
anim
market
suggest
anim
origin
initi
spread
human
subsequ
investig
reveal
crowd
seafood
market
boost
circul
novel
cov
spread
whole
citi
earli
decemb
wherea
base
genom
data
viru
like
began
spread
person
person
earli
decemb
even
earli
late
novemb
first
document
human
case
date
back
novemb
novel
human
cov
hcov
betacoronaviru
genet
relat
sever
acut
respiratori
syndrom
sar
cov
distantli
relat
middl
east
respiratori
syndrom
cov
merscov
design
sar
type
cov
similar
hypervirul
hcov
put
anim
origin
like
descend
relat
bat
cov
spill
human
either
directli
adapt
anoth
anim
speci
malayan
pangolin
lam
et
al
highli
relat
genet
nt
sarslik
bat
cov
induc
diseas
refer
coronaviru
diseas
affect
respiratori
tract
number
patient
display
sever
pneumonia
requir
hospitalis
admiss
intermedi
intens
care
unit
unlik
sar
mer
characteris
low
lethal
rate
high
frequenc
asymptomat
paucisymptomat
infect
like
favour
spread
new
pandem
lai
et
al
start
spread
global
februari
march
potenti
spill
exposur
viral
rna
note
companion
anim
like
due
strict
social
interact
human
rna
detect
two
dog
cat
without
clinic
sign
hong
kong
cat
gastroenter
respiratori
sign
bruxel
live
close
contact
infect
covid
emerg
sarscov
first
highli
pathogen
hcov
inform
scarc
hcov
wherea
extens
knowledg
veterinari
medicin
anim
cov
evolut
pathobiolog
infecti
bronchiti
viru
ibv
poultri
felin
infecti
periton
viru
fipv
known
sinc
earli
repres
anim
exampl
cov
evolv
chang
tissu
tropism
virul
decaro
lorusso
press
addit
swine
cov
paradigmat
cov
may
cross
speci
barrier
infect
new
host
transmiss
gastroenter
viru
swine
tgev
alphacoronaviru
like
origin
close
relat
canin
coronaviru
ccov
turn
tgev
gave
rise
less
virul
porcin
respiratori
cov
prcov
also
tgevlik
ccov
gener
recombin
n
termin
end
gene
decaro
et
al
two
addit
swine
alphacoronavirus
emerg
recent
porcin
epidem
diarrhoea
viru
pedv
sever
acut
diarrhoea
syndrom
cov
sadscov
deriv
cov
circul
bat
betacoronaviru
porcin
haemagglutin
encephalomyel
viru
phev
deriv
bovin
cov
turn
believ
descend
bat
viru
adapt
rodent
speci
recent
porcin
deltacoronaviru
pdcov
caus
agent
sever
diarrhoea
outbreak
north
america
asia
emerg
avian
deltacorovirus
wang
et
al
observ
repeat
event
interspeci
transmiss
anim
cov
reli
except
abil
cov
expand
host
rang
strongli
support
natur
origin
confut
conspiraci
theori
laboratori
origin
anim
cov
may
also
repres
excel
host
model
develop
vaccin
could
requir
much
time
initi
anticip
major
vaccin
licens
veterinari
market
develop
cov
caus
enter
infect
bcov
swine
cov
tgev
pedv
vaccin
intend
parenter
use
pregnant
cowssow
oral
use
sow
tgev
pedv
transfer
matern
immun
offspr
protect
first
week
life
suscept
sever
diseas
vaccin
take
advantag
differ
technolog
sinc
bcovtgev
vaccin
inactiv
modifiedl
viru
mlv
formul
produc
accord
tradit
protocol
pedv
prophylaxi
addit
kill
mlv
prepar
vectorbas
vaccin
express
spike
protein
commerci
avail
gerdt
zakhartchouk
saif
bcov
also
respons
respiratori
diseas
monthold
calv
older
anim
specif
vaccin
current
avail
prevent
respiratori
diseas
also
vaccin
ie
ccov
introduc
market
use
year
later
abandon
costeffect
evalu
ccov
vaccin
administ
parenter
induc
good
system
poor
mucos
immun
protect
pup
infect
virul
viru
pratelli
et
al
pratelli
et
al
decaro
et
al
licens
anim
cov
vaccin
target
prevent
respiratori
cov
infect
ibv
vaccin
chicken
vaccin
administ
parenter
may
protect
infect
reduc
sever
respiratori
sign
prevent
involv
kidney
reproduct
tract
saif
one
main
issu
parenter
vaccin
respiratori
cov
anim
trigger
strong
local
immun
usual
repres
mucos
immunoglobulin
iga
mucos
immun
even
prevent
infect
abl
reduc
viral
shed
term
durat
extent
sever
respiratori
diseas
also
may
case
primarili
affect
respiratori
tract
lesser
extent
enter
tract
limit
viremia
andor
system
involv
wong
et
al
also
durat
immun
elicit
natur
infect
known
yet
anim
cov
immun
infect
may
short
durat
instanc
felin
enter
coronaviru
fecv
may
induc
shortterm
immun
confer
protect
reinfect
fecv
avirul
biotyp
felin
coronaviru
fcov
precursor
hypervirul
biotyp
fipv
addi
et
al
interestingli
fip
vaccin
paradigmat
difficult
develop
vaccin
human
cov
may
fip
sporad
highli
lethal
diseas
cat
origin
consequ
switch
fecv
fipv
due
specif
mutat
spike
protein
gene
chang
et
al
despit
consider
effort
far
effect
fipv
vaccin
develop
one
main
issu
experiment
vaccin
trigger
antibodydepend
enhanc
ade
mechan
caus
sever
diseas
immunis
anim
control
cat
viru
challeng
german
et
al
ade
trigger
antibodymedi
viru
entri
macrophag
via
ig
fc
receptor
might
repres
obstacl
develop
specif
vaccin
rauch
et
al
altern
mechan
ade
describ
recent
merscov
neutral
antibodi
bind
spike
protein
trigger
conform
chang
spike
mediat
viral
entri
igg
fc
receptorexpress
cell
canon
viralreceptordepend
pathway
wan
et
al
analog
cat
affect
fip
human
patient
sever
cytokin
storm
syndrom
frequent
observ
requir
treatment
hyperinflamm
reduc
fatal
rate
cytokin
storm
time
caus
immunosuppress
characteris
increas
interleukin
il
granulocytecoloni
stimul
factor
induc
protein
monocyt
chemoattract
protein
macrophag
inflammatori
protein
tumour
necrosi
mehta
et
al
notabl
similar
cytokin
pattern
observ
cat
fip
paltrinieri
tocilizumab
receptor
blocker
monoclon
antibodi
seem
highli
effect
reduc
sever
induc
pneumonia
faval
et
al
number
antivir
test
control
fip
sever
unsuccess
attempt
research
effort
focus
two
promis
antivir
class
name
proteas
inhibitor
nucleosid
analogu
inhibit
viral
replic
either
block
viral
polyprotein
cleavag
termin
viral
rna
transcript
treatment
cat
natur
occur
fip
proteas
inhibitor
induc
signific
remiss
diseas
sign
regress
lesion
anim
although
six
anim
remain
remiss
long
period
pedersen
et
al
contrast
longterm
repeat
treatment
nucleosid
analogu
success
cat
fip
one
anim
respond
retreat
pedersen
et
al
addit
drug
abl
stop
faecal
shed
fecv
natur
infect
cat
addi
et
al
interestingli
similar
compound
adenosin
nucleosid
monophosph
prodrug
activ
molecul
remdesivir
larg
employ
potenti
antivir
drug
shown
effect
lopinavir
similar
act
viral
proteas
baden
rubin
consid
longterm
experi
gain
anim
cov
veterinari
medicin
could
help
forg
better
understand
origin
spread
drive
futur
research
human
medicin
toward
develop
immunogen
safe
vaccin
effect
antivir
drug
success
failur
encount
prophylaxi
treatment
anim
cov
diseas
fip
might
use
address
issu
relat
one
health
approach
likewis
atyp
pneumonia
evid
pig
infect
prcv
despit
mild
clinic
sign
pneumonia
cattl
trigger
bcov
complex
respiratori
bacteria
stress
transport
may
provid
model
understand
factor
precipit
sever
pneumonia
patient
progress
deforest
anthrop
natur
environ
larg
compromis
ecolog
nich
cov
wildlif
usual
confin
also
human
consumpt
endang
wildlif
even
demonstr
play
role
onset
restrict
ban
particularli
unsanitari
condit
preval
live
anim
market
consid
anim
cov
spill
human
three
differ
occas
short
time
span
two
decad
rever
manag
environ
fundament
prevent
futur
emerg
pandem
cov
circumst
veterinari
medicin
support
polici
maker
adopt
promot
sound
sustain
measur
manag
environ
anim
advanc
global
one
health
movement
